More than half of employers in the Business Group on Health’s annual survey said GLP-1 drugs were impacting costs to a “very great” or “great” extent.
More than half of employers in the Business Group on Health’s annual survey said GLP-1 drugs were impacting costs to a “very great” or “great” extent.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More